BIOMAT Database Logo BIOMAT Database Logo

Effect of D-penicillamine on neuromuscular junction in patients with Wilson disease. 2004

R N Komal Kumar, and S A Patil, and A B Taly, and M Nirmala, and S Sinha, and G R Arunodaya
Department of Neurology, National Institute of Mental Health and Neurosciences, Bangalore, Karnataka, India.

UI MeSH Term Description Entries
D008297 Male Males
D009157 Myasthenia Gravis A disorder of neuromuscular transmission characterized by fatigable weakness of cranial and skeletal muscles with elevated titers of ACETYLCHOLINE RECEPTORS or muscle-specific receptor tyrosine kinase (MuSK) autoantibodies. Clinical manifestations may include ocular muscle weakness (fluctuating, asymmetric, external ophthalmoplegia; diplopia; ptosis; and weakness of eye closure) and extraocular fatigable weakness of facial, bulbar, respiratory, and proximal limb muscles. The disease may remain limited to the ocular muscles (ocular myasthenia). THYMOMA is commonly associated with this condition. Anti-MuSK Myasthenia Gravis,MuSK MG,MuSK Myasthenia Gravis,Muscle-Specific Receptor Tyrosine Kinase Myasthenia Gravis,Muscle-Specific Tyrosine Kinase Antibody Positive Myasthenia Gravis,Myasthenia Gravis, Generalized,Myasthenia Gravis, Ocular,Anti MuSK Myasthenia Gravis,Generalized Myasthenia Gravis,Muscle Specific Receptor Tyrosine Kinase Myasthenia Gravis,Muscle Specific Tyrosine Kinase Antibody Positive Myasthenia Gravis,Myasthenia Gravis, Anti-MuSK,Myasthenia Gravis, MuSK,Ocular Myasthenia Gravis
D009469 Neuromuscular Junction The synapse between a neuron and a muscle. Myoneural Junction,Nerve-Muscle Preparation,Junction, Myoneural,Junction, Neuromuscular,Junctions, Myoneural,Junctions, Neuromuscular,Myoneural Junctions,Nerve Muscle Preparation,Nerve-Muscle Preparations,Neuromuscular Junctions,Preparation, Nerve-Muscle,Preparations, Nerve-Muscle
D010396 Penicillamine 3-Mercapto-D-valine. The most characteristic degradation product of the penicillin antibiotics. It is used as an antirheumatic and as a chelating agent in Wilson's disease. Dimethylcysteine,Mercaptovaline,beta,beta-Dimethylcysteine,Copper Penicillaminate,Cuprenil,Cuprimine,D-3-Mercaptovaline,D-Penicillamine,Metalcaptase,D 3 Mercaptovaline,D Penicillamine,Penicillaminate, Copper,beta,beta Dimethylcysteine
D011446 Prospective Studies Observation of a population for a sufficient number of persons over a sufficient number of years to generate incidence or mortality rates subsequent to the selection of the study group. Prospective Study,Studies, Prospective,Study, Prospective
D011950 Receptors, Cholinergic Cell surface proteins that bind acetylcholine with high affinity and trigger intracellular changes influencing the behavior of cells. Cholinergic receptors are divided into two major classes, muscarinic and nicotinic, based originally on their affinity for nicotine and muscarine. Each group is further subdivided based on pharmacology, location, mode of action, and/or molecular biology. ACh Receptor,Acetylcholine Receptor,Acetylcholine Receptors,Cholinergic Receptor,Cholinergic Receptors,Cholinoceptive Sites,Cholinoceptor,Cholinoceptors,Receptors, Acetylcholine,ACh Receptors,Receptors, ACh,Receptor, ACh,Receptor, Acetylcholine,Receptor, Cholinergic,Sites, Cholinoceptive
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D004797 Enzyme-Linked Immunosorbent Assay An immunoassay utilizing an antibody labeled with an enzyme marker such as horseradish peroxidase. While either the enzyme or the antibody is bound to an immunosorbent substrate, they both retain their biologic activity; the change in enzyme activity as a result of the enzyme-antibody-antigen reaction is proportional to the concentration of the antigen and can be measured spectrophotometrically or with the naked eye. Many variations of the method have been developed. ELISA,Assay, Enzyme-Linked Immunosorbent,Assays, Enzyme-Linked Immunosorbent,Enzyme Linked Immunosorbent Assay,Enzyme-Linked Immunosorbent Assays,Immunosorbent Assay, Enzyme-Linked,Immunosorbent Assays, Enzyme-Linked
D005260 Female Females
D005500 Follow-Up Studies Studies in which individuals or populations are followed to assess the outcome of exposures, procedures, or effects of a characteristic, e.g., occurrence of disease. Followup Studies,Follow Up Studies,Follow-Up Study,Followup Study,Studies, Follow-Up,Studies, Followup,Study, Follow-Up,Study, Followup

Related Publications

R N Komal Kumar, and S A Patil, and A B Taly, and M Nirmala, and S Sinha, and G R Arunodaya
Peritoneal dialysis with D-penicillamine in Wilson disease.
October 1985, The Journal of pediatrics,
R N Komal Kumar, and S A Patil, and A B Taly, and M Nirmala, and S Sinha, and G R Arunodaya
Effect of D-penicillamine on liver fibrosis and inflammation in Wilson disease.
December 2008, Experimental and clinical transplantation : official journal of the Middle East Society for Organ Transplantation,
R N Komal Kumar, and S A Patil, and A B Taly, and M Nirmala, and S Sinha, and G R Arunodaya
Relapse following withdrawal of D-penicillamine from combination (D-penicillamine + zinc) therapy in hepatic Wilson disease.
May 2024, Journal of pediatric gastroenterology and nutrition,
R N Komal Kumar, and S A Patil, and A B Taly, and M Nirmala, and S Sinha, and G R Arunodaya
D-Penicillamine-induced ANCA-associated crescentic glomerulonephritis in Wilson disease.
November 2007, American journal of kidney diseases : the official journal of the National Kidney Foundation,
R N Komal Kumar, and S A Patil, and A B Taly, and M Nirmala, and S Sinha, and G R Arunodaya
[Oral zinc in Wilson disease--an alternative to D-penicillamine].
January 1985, Zeitschrift fur Gastroenterologie,
R N Komal Kumar, and S A Patil, and A B Taly, and M Nirmala, and S Sinha, and G R Arunodaya
D-penicillamine-induced neuromuscular disease in guinea pigs.
April 1982, Experimental neurology,
R N Komal Kumar, and S A Patil, and A B Taly, and M Nirmala, and S Sinha, and G R Arunodaya
[Changes in zinc metabolism during long-term D-penicillamine treatment of patients with Wilson-Konovalov disease].
January 1984, Zhurnal nevropatologii i psikhiatrii imeni S.S. Korsakova (Moscow, Russia : 1952),
R N Komal Kumar, and S A Patil, and A B Taly, and M Nirmala, and S Sinha, and G R Arunodaya
Gabapentin as a rescue drug in D-penicillamine-induced status dystonicus in patients with Wilson disease.
January 2010, Neurology India,
R N Komal Kumar, and S A Patil, and A B Taly, and M Nirmala, and S Sinha, and G R Arunodaya
Metal element excretion in 24-h urine in patients with Wilson disease under treatment of D-penicillamine.
May 2012, Biological trace element research,
R N Komal Kumar, and S A Patil, and A B Taly, and M Nirmala, and S Sinha, and G R Arunodaya
Oral complications associated with D-penicillamine treatment for Wilson disease: a clinicopathologic report.
August 2010, Journal of periodontology,
Copied contents to your clipboard!